EVOTEC (EVT.F)
-Frankfurt 2.82 
0.01(0.36%) 3:27AM EDT
| Prev Close: | 2.81 |
|---|
| Open: | 2.81 |
|---|
| Bid: | 2.81 |
|---|
| Ask: | 2.82 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 2.81 - 2.82 |
|---|
| 52wk Range: | 2.07 - 3.06 |
|---|
| Volume: | 5,050 |
|---|
| Avg Vol (3m): | 44,571 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in EUR.
Headlines
- Evotec and Harvard University to Collaborate on Development of New Class of AntibacterialsGlobeNewswire(Thu, May 16)
- Evotec Q1 2013: Driving Innovation EfficiencyGlobeNewswire(Tue, May 14)
- Evotec to Report First Quarter Results on 14 May 2013GlobeNewswire(Tue, May 7)
- Dana-Farber's Belfer Institute for Applied Cancer Science and Evotec Establish Collaboration in OncologyGlobeNewswire(Tue, Apr 30)
- Evotec Expands Compound Management Capability to East Coast of the United StatesGlobeNewswire(Mon, Apr 29)
- Evotec AG: New Hormone to Treat Diabetes Published in "Cell"GlobeNewswire(Fri, Apr 26)
- Evotec Extends Drug Discovery Alliance With GenentechGlobeNewswire(Mon, Apr 22)
- Forward Step by Step With Action Plan 2016 - Continued Revenue Growth - Significant Pipeline ProgressGlobeNewswire(Tue, Mar 26)
- Evotec AG: Fiscal Year 2012 Results Presentation on 26 March 2013 Live on the InternetGlobeNewswire(Tue, Mar 19)
- Evotec Releases Corporate UpdateGlobeNewswire(Mon, Mar 18)
Reports
- No Reports available for EVT.F at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
No business summary available forEVT.F.